NAN 0.68% $4.42 nanosonics limited

NAN Why I Should Buy Now

  1. 20,543 Posts.
    lightbulb Created with Sketch. 79
    1. Nan has a clear and reliable strategy for future development and a revolutionary monopolistic product (Trophon 2).

    2. Thecompany also just achieved regulatory approvals in key markets and is selectedby the guidelines in both Germany and France.
    3. Thecompany also plans to rapidly expand into worldwide markets during FY19.Therevised reseller agreement with GE healthcare underlines this.
    4. The company has developed a unique disinfectiontechnology which is the first major innovation in High-Level Disinfection (HLD)for ultrasound probes. The products include Trophon machine, including TrophonEPR (first generation), Trophon2, consumables & accessories, and are soldin 3 different types of selling models.
    5. The main product “Trophon” is an automated systemthat delivers HLD of ultrasound probes which is highly effective in killingbacteria, fungi, and viruses including the highly resistant HPV virus. NorthAmerica is their most substantial market making up 89.62% of total revenue inFY18.
    6. They alsooperate in some European and Asian countries, while still exploring chances tointroduce their technology to other new countries. In addition, theirsuccessful business model, customer experience, product innovation, operationalexcellence, people engagement, and value creation, lay the foundation forsuccess.

watchlist Created with Sketch. Add NAN (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.367B
Open High Low Value Volume
$4.36 $4.44 $4.36 $3.362M 763.7K

Buyers (Bids)

No. Vol. Price($)
3 17691 $4.41

Sellers (Offers)

Price($) Vol. No.
$4.42 40681 6
View Market Depth
Last update - 16.10pm 26/03/2019 (20 minute delay) ?
0.030 ( 0.84 %)
Open High Low Volume
$4.41 $4.44 $4.37 239787
Last updated 15.59pm 26/03/2019 (live) ?
NAN (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.